Boston Globe Story Quotes WPI Professor on FDA’s Approval of Anti-clotting Drug
A recent article in the Boston Globe spotlighted the FDA’s approval of ATryn, an anti-clotting drug made using genetically modified animals (a process called pharming). This was the first time the FDA approved a drug produced with this novel technique. The approval is seen as a door-opener to other “pharmed” pharmaceuticals.
The article cites Eric Overstrom, head of biology and biotechnology and director of WPI’s Life Sciences and Bioengineering center at Gateway Park, who collaborated with the biotech company behind this revolutionary drug development technique.
Read the Globe article
February 11, 2009